{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:42:40Z","timestamp":1791265360059,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T00:00:00Z","timestamp":1034035200000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND<\/jats:bold>\n                    : Hemovigilance networks have been introduced in several countries to improve knowledge of blood transfusion\u2010related morbidity and mortality. The general organization of the French network and its results from 1994 through March 1999 are presented here.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>STUDY DESIGN AND METHODS<\/jats:bold>\n                    : The hemovigilance network relies on blood transfusion centers and hospital correspondents, who analyze unexpected and untoward blood transfusion\u2010related effects and transmit a Transfusion Incident Report (TIR) to a national database (Transfusion Incident Reports Electronic Data Management [GIFIT]).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS<\/jats:bold>\n                    : As of March 1, 1999, the GIFIT database contained 24,234 TIRs related to incidents that occurred from the start of the hemovigilance network until December 31, 1998. The network was not fully implemented until 1996; but the reporting rate seems to have since stabilized at approximately 7000 per year (2.5 reports per 1000 blood components). The highest reporting rate is observed with platelet concentrates (4.02\/1000), followed by RBCs (1.71\/1000) and FFP (0.34\/1000). Bacterial contamination quickly appeared as a major cause of morbidity and mortality (185 cases and 18 fatalities). However, a general trend of reduction in this type of incident was observed over time, which can be attributed to adoption of several preventive measures. In contrast, major ABO mismatchings during RBC transfusion remained at a constant rate throughout this period and accounted for six fatalities. After the implementation of universal WBC reduction, some incidents known to be related to WBCs, such as nonhemolytic febrile transfusion reactions (NHFTR) and HLA immunization, were dramatically reduced.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION<\/jats:bold>\n                    : Hemovigilance is an important tool not only to analyze blood transfusion incidents, but also to measure the effects of new processes or corrective actions at a national level.\n                  <\/jats:p>","DOI":"10.1046\/j.1537-2995.2002.00202.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T17:48:45Z","timestamp":1047491325000},"page":"1356-1364","source":"Crossref","is-referenced-by-count":207,"title":["Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998"],"prefix":"10.1111","volume":"42","author":[{"given":"Georges","family":"Andreu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Debeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Rebibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Janvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,10,8]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7720077.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05454.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05453.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7720082.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05455.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7720067.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(05)80037-0"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(98)80033-3"},{"key":"e_1_2_7_10_2","first-page":"415","article-title":"A quoi sert l'h\u00e9movigilance?","volume":"5","author":"Quaranta JF","year":"1998","journal-title":"Transfus Clin Biol"},{"key":"e_1_2_7_11_2","unstructured":"D\u00e9cret no. 94\u201068 du 24 janvier. Relatif aux r\u00e8gles d'h\u00e9movigilance pris pour application de l'article L.666\u201012 du code de la sant\u00e9 publique et modifiant ce code (deuxi\u00e8me partie: d\u00e9crets en Conseil d'Etat) 1994."},{"key":"e_1_2_7_12_2","unstructured":"Circulaire DGS\/DH no. 40 du 7 juillet. Relative au d\u00e9cret no. 94\u201068 du 24 janvier 1994 sur l'h\u00e9movigilance pris pour application de l'article L.666\u201012 du code de la sant\u00e9 publique et modifiant ce code (deuxi\u00e8me partie: d\u00e9crets en Conseil d'Etat) 1994."},{"key":"e_1_2_7_13_2","unstructured":"Loi no. 98\u2010535 du 1er juillet. Relative au renforcement de la veille sanitaire et du contr\u00f4le de la s\u00e9curit\u00e9 sanitaire des produits destin\u00e9s \u00e0 l'homme. J Officiel la R\u00e9publique Fran\u00e7aise 2 juillet 1998;15:10056."},{"key":"e_1_2_7_14_2","unstructured":"D\u00e9cret no. 99\u2010142 du 4 mars. Relatif \u00e0 l'Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des produits de sant\u00e9 et modifiant le code de la sant\u00e9 publique (deuxi\u00e8me partie: d\u00e9crets en Conseil d'Etat) 1999."},{"key":"e_1_2_7_15_2","first-page":"151","volume-title":"Actualit\u00e9s sur les solut\u00e9s de rem\u2010 plissage en anesth\u00e9sie. Conf\u00e9rences D'actualisation 2000, 42\u00e8me Congr\u00e8s National D'anesth\u00e9sie et de R\u00e9animation.","author":"Forestier F","year":"2000"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(96)00939-3"},{"key":"e_1_2_7_17_2","unstructured":"Odent\u2010Malaure H Gallon P Dumontier P Foulhoux AC Lamy B Le Petit JC.Transfusion\u2010related acute lung injury (TRALI) during plasmapheresis and transfusion.Paris: ISBT 15\u20108 July 2001."},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101207.x"},{"key":"e_1_2_7_20_2","unstructured":"Circulaire DGS\/DH\/AFS no. 85 du 10 OCT. Relative \u00e0 la conduite \u00e0 tenir en cas d'accident bact\u00e9rien li\u00e9\u00e0 la transfusion sanguine. BO Minist\u00e8re des Affaires Sociales 1995;46:93\u2010107.20."},{"key":"e_1_2_7_21_2","unstructured":"Recommandation AFS\/DMS du 20 SEPT. Relative \u00e0 la recommandation sur l'hygi\u00e8ne et l'antisepsie cutan\u00e9e du pr\u00e9leveur et de la peau au site de ponction dans le cadre du pr\u00e9l\u00e8vement en transfusion sanguine 1996."},{"key":"e_1_2_7_22_2","first-page":"56S","article-title":"Systematic microbiological control of platelet concentrates (PC) using an automated culture system: analysis of 5015 results.","volume":"37","author":"Morel P","year":"1997","journal-title":"Transfusion"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41010074.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41070862.x"},{"key":"e_1_2_7_25_2","unstructured":"Circulaire DGS\/DH\/AFS no. 98\/118 du 20 f\u00e9vrier 1998. Relative \u00e0 la mise en place de la d\u00e9leucocytation syst\u00e9matique des PSL (concentr\u00e9s de globules rouges et concentr\u00e9s de plaquettes de base) et aux mesures n\u00e9cessaire \u00e0 la mont\u00e9e en charge de ce dispositif. BO Minist\u00e8re des Affaires Sociales (1998)."},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05414.x"},{"key":"e_1_2_7_27_2","unstructured":"Serious Hazards of Transfusions. Annual Report 1999\u20102000. Brentwood (UK): National Blood Service; 2001."},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31791368338.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33693296817.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2002.00202.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2002.00202.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T13:32:11Z","timestamp":1694352731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2002.00202.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1046\/j.1537-2995.2002.00202.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2002.00202.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}